Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Illumina Inc ha un obiettivo di prezzo consensuale di $131.55, basato sulle valutazioni degli ultimi 24 analisti. Il massimo è $200 emesso da Leerink Partners il ottobre 17, 2024, mentre il minimo è $80 emesso da Citigroup il luglio 9, 2025. Le ultime 3 valutazioni degli analisti sono state pubblicate da Evercore ISI Group, Barclays e Morgan Stanley il ottobre 7, 2025, ottobre 2, 2025 e agosto 4, 2025. Con un obiettivo di prezzo medio di $110.67 tra Evercore ISI Group, Barclays e Morgan Stanley, c'è un cambiamento implicito del 15.75% upside per Illumina Inc secondo queste ultime valutazioni degli analisti.
1calcolato in base alle valutazioni degli analisti
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
10/07/2025 | 38.06% | Evercore ISI Group | $135 → $132 | Maintains | Outperform | |||
10/02/2025 | -0.64% | Barclays | $90 → $95 | Maintains | Underweight | |||
08/04/2025 | 9.82% | Morgan Stanley | $100 → $105 | Maintains | Equal-Weight | |||
08/01/2025 | 31.79% | RBC Capital | $118 → $126 | Maintains | Outperform | |||
08/01/2025 | 9.82% | Canaccord Genuity | $99 → $105 | Maintains | Hold | |||
08/01/2025 | -5.87% | Barclays | $85 → $90 | Maintains | Underweight | |||
07/28/2025 | 9.82% | Baird | $84 → $105 | Maintains | Neutral | |||
07/11/2025 | 30.74% | Scotiabank | → $125 | Downgrade | Sector Outperform → Sector Perform | |||
07/09/2025 | -16.33% | Citigroup | $85 → $80 | Downgrade | Neutral → Sell | |||
07/08/2025 | 33.88% | Evercore ISI Group | $116 → $128 | Maintains | Outperform | |||
06/24/2025 | -11.1% | Barclays | $77 → $85 | Maintains | Underweight | |||
06/11/2025 | 3.55% | Canaccord Genuity | $87 → $99 | Maintains | Hold | |||
05/20/2025 | 9.82% | Stephens & Co. | $105 → $105 | Reiterates | Overweight → Overweight | |||
05/15/2025 | 93.49% | Piper Sandler | $190 → $185 | Maintains | Overweight | |||
05/12/2025 | 4.59% | Morgan Stanley | $136 → $100 | Maintains | Equal-Weight | |||
05/12/2025 | -9.01% | Canaccord Genuity | $92 → $87 | Maintains | Hold | |||
05/09/2025 | -11.1% | JP Morgan | $120 → $85 | Maintains | Neutral | |||
05/09/2025 | 19.23% | Guggenheim | $122 → $114 | Maintains | Buy | |||
04/29/2025 | -3.78% | Canaccord Genuity | $115 → $92 | Maintains | Hold | |||
04/10/2025 | -19.46% | Barclays | $100 → $77 | Maintains | Underweight | |||
04/08/2025 | 17.14% | RBC Capital | $128 → $112 | Maintains | Outperform | |||
04/07/2025 | -11.1% | Citigroup | $90 → $85 | Maintains | Neutral | |||
03/12/2025 | 33.88% | RBC Capital | $247 → $128 | Maintains | Outperform | |||
03/11/2025 | 63.16% | Stephens & Co. | $156 → $156 | Reiterates | Overweight → Overweight | |||
03/11/2025 | 20.28% | Canaccord Genuity | $135 → $115 | Maintains | Hold | |||
03/05/2025 | -5.87% | Baird | $127 → $90 | Maintains | Neutral | |||
03/04/2025 | -5.87% | Citigroup | $130 → $90 | Maintains | Neutral | |||
02/11/2025 | 42.24% | Morgan Stanley | $150 → $136 | Maintains | Equal-Weight | |||
02/10/2025 | 98.72% | Piper Sandler | $185 → $190 | Maintains | Overweight | |||
02/10/2025 | 4.59% | Barclays | $130 → $100 | Downgrade | Equal-Weight → Underweight | |||
02/07/2025 | 158.34% | RBC Capital | $250 → $247 | Maintains | Outperform | |||
02/07/2025 | 41.2% | Canaccord Genuity | $145 → $135 | Maintains | Hold | |||
02/07/2025 | 56.89% | Guggenheim | $170 → $150 | Maintains | Buy | |||
02/03/2025 | 35.97% | Barclays | $145 → $130 | Maintains | Equal-Weight | |||
01/13/2025 | 56.89% | Morgan Stanley | $156 → $150 | Maintains | Equal-Weight | |||
12/11/2024 | 72.58% | Citigroup | $190 → $165 | Downgrade | Buy → Neutral | |||
11/12/2024 | 63.16% | Morgan Stanley | → $156 | Reinstates | → Equal-Weight | |||
11/12/2024 | 92.45% | Stephens & Co. | $170 → $184 | Maintains | Overweight | |||
11/11/2024 | 93.49% | Piper Sandler | $195 → $185 | Maintains | Overweight | |||
11/06/2024 | 45.38% | Baird | $124 → $139 | Maintains | Neutral | |||
11/05/2024 | 85.13% | TD Cowen | $166 → $177 | Maintains | Buy | |||
11/05/2024 | 51.66% | UBS | $133 → $145 | Maintains | Neutral | |||
11/05/2024 | 165.66% | RBC Capital | $252 → $254 | Maintains | Outperform | |||
11/05/2024 | 46.43% | JP Morgan | $125 → $140 | Maintains | Neutral | |||
11/05/2024 | 98.72% | Citigroup | $155 → $190 | Maintains | Buy | |||
11/05/2024 | 51.66% | Barclays | $135 → $145 | Maintains | Equal-Weight | |||
11/05/2024 | 51.66% | Canaccord Genuity | $130 → $145 | Maintains | Hold | |||
10/17/2024 | 109.18% | Leerink Partners | — | $160 → $200 | Maintains | Outperform | ||
10/17/2024 | 88.26% | HSBC | → $180 | Upgrade | Hold → Buy | |||
10/15/2024 | 41.2% | Barclays | $125 → $135 | Maintains | Equal-Weight | |||
10/10/2024 | 163.57% | RBC Capital | $252 → $252 | Reiterates | Outperform → Outperform | |||
08/28/2024 | 56.89% | Argus Research | → $150 | Upgrade | Hold → Buy | |||
08/16/2024 | 61.07% | Daiwa Capital | $120 → $154 | Upgrade | Neutral → Buy | |||
08/15/2024 | 71.53% | Scotiabank | $176 → $164 | Maintains | Sector Outperform | |||
08/14/2024 | 50.61% | TD Cowen | $126 → $144 | Upgrade | Hold → Buy | |||
08/14/2024 | 153.11% | RBC Capital | $242 → $242 | Reiterates | Outperform → Outperform | |||
08/14/2024 | 30.74% | Barclays | → $125 | Upgrade | Underweight → Equal-Weight | |||
08/13/2024 | 103.95% | Piper Sandler | $200 → $195 | Maintains | Overweight | |||
08/07/2024 | 31.79% | TD Cowen | $122 → $126 | Maintains | Hold | |||
08/07/2024 | 62.12% | Citigroup | $140 → $155 | Maintains | Buy | |||
08/07/2024 | 30.74% | JP Morgan | $130 → $125 | Maintains | Neutral | |||
08/07/2024 | 153.11% | RBC Capital | $242 → $242 | Reiterates | Outperform → Outperform | |||
08/07/2024 | 29.69% | Baird | $119 → $124 | Maintains | Neutral | |||
08/07/2024 | 39.11% | UBS | $131 → $133 | Maintains | Neutral | |||
07/10/2024 | 77.81% | Stephens & Co. | $170 → $170 | Reiterates | Overweight → Overweight | |||
07/10/2024 | 46.43% | Citigroup | → $140 | Upgrade | Neutral → Buy | |||
07/01/2024 | 153.11% | RBC Capital | $249 → $242 | Maintains | Outperform | |||
06/11/2024 | 83.04% | Evercore ISI Group | $195 → $175 | Maintains | Outperform | |||
06/06/2024 | 27.6% | TD Cowen | $140 → $122 | Maintains | Hold | |||
06/03/2024 | 20.28% | Jefferies | → $115 | Assumes | → Hold | |||
05/07/2024 | 77.81% | Stephens & Co. | $170 → $170 | Reiterates | Overweight → Overweight | |||
05/06/2024 | 84.08% | Scotiabank | $185 → $176 | Maintains | Sector Outperform | |||
05/03/2024 | 33.88% | Baird | $125 → $128 | Maintains | Neutral | |||
04/10/2024 | 77.81% | Stephens & Co. | $170 → $170 | Reiterates | Overweight → Overweight | |||
04/10/2024 | 4.59% | Barclays | $85 → $100 | Maintains | Underweight | |||
04/09/2024 | 164.62% | RBC Capital | $253 → $253 | Reiterates | Outperform → Outperform | |||
03/20/2024 | — | OTR Global | — | — | Downgrade | Positive → Mixed | ||
02/14/2024 | 77.81% | Stephens & Co. | $170 → $170 | Reiterates | Overweight → Overweight | |||
02/09/2024 | 169.85% | RBC Capital | $258 → $258 | Reiterates | Outperform → Outperform | |||
01/25/2024 | -16.33% | Barclays | $50 → $80 | Maintains | Underweight | |||
01/04/2024 | — | TD Cowen | — | Downgrade | Outperform → Market Perform | |||
12/19/2023 | 169.85% | RBC Capital | $260 → $258 | Maintains | Outperform | |||
12/19/2023 | — | Scotiabank | — | Upgrade | Sector Perform → Sector Outperform | |||
12/18/2023 | — | Scotiabank | — | Upgrade | Sector Perform → Sector Outperform | |||
12/14/2023 | 62.12% | Guggenheim | → $155 | Initiates | → Buy | |||
12/14/2023 | 77.81% | Stephens & Co. | → $170 | Initiates | → Overweight | |||
12/13/2023 | — | Wolfe Research | — | Initiates | → Outperform | |||
12/12/2023 | 4.59% | B of A Securities | $140 → $100 | Downgrade | Neutral → Underperform | |||
12/11/2023 | 25.51% | Citigroup | $85 → $120 | Upgrade | Sell → Neutral | |||
11/13/2023 | 98.72% | Piper Sandler | $200 → $190 | Maintains | Overweight | |||
11/10/2023 | 25.51% | Canaccord Genuity | $210 → $120 | Downgrade | Buy → Hold | |||
10/16/2023 | 109.18% | Piper Sandler | $275 → $200 | Maintains | Overweight | |||
10/12/2023 | 109.18% | Stifel | → $200 | Reiterates | Buy → Buy | |||
09/29/2023 | 109.18% | Stifel | $225 → $200 | Maintains | Buy | |||
09/29/2023 | 4.59% | Barclays | $150 → $100 | Maintains | Underweight | |||
09/28/2023 | 16.1% | Bernstein | → $111 | Initiates | → Underperform | |||
09/01/2023 | 151.02% | Evercore ISI Group | → $240 | Reiterates | Outperform → Outperform | |||
08/16/2023 | 198.09% | Canaccord Genuity | $300 → $285 | Maintains | Buy | |||
08/15/2023 | 187.63% | Piper Sandler | $290 → $275 | Maintains | Overweight | |||
08/14/2023 | 145.79% | HSBC | $270 → $235 | Maintains | Buy |
L'ultimo obiettivo di prezzo per Illumina (NASDAQ:ILMN) è stato riportato da {{analyst} in data {{date}}. La società di analisi ha fissato un obiettivo di prezzo per $132.00 prevedendo che ILMN raggiunga rise entro 12 mesi (un possibile 38.06% upside).
L'ultima valutazione degli analisti per Illumina (NASDAQ:ILMN) è stato fornita da Evercore ISI Group e Illumina mantenuto il suo rating outperform.
L'ultima revisione al rialzo di Illumina Inc è avvenuta il ottobre 17, 2024, quando HSBC ha alzato il suo obiettivo di prezzo a $180. In precedenza HSBC aveva a hold per Illumina Inc.
L'ultima revisione al ribasso di Illumina Inc si è verificata il luglio 11, 2025, quando Scotiabank ha modificato il suo obiettivo di prezzo da N/A a $125 per Illumina Inc.
Gli analisti giungono alle valutazioni dei titoli dopo aver fatto ricerche approfondite, che comprendono l'esame dei bilanci pubblici, i colloqui con i dirigenti e i clienti di Illumina e l'ascolto delle comunicazioni degli utili. La maggior parte degli analisti svolge questa attività ogni tre mesi, quindi dovresti ricevere 4 valutazioni all'anno per azienda e per società. L'ultima valutazione di Illumina è stata depositata il ottobre 7, 2025, quindi dovresti aspettarti che la prossima valutazione sia disponibile intorno a ottobre 7, 2026.
Sebbene le valutazioni siano soggettive e possano cambiare, l'ultima valutazione di Illumina (ILMN) è stata una mantenuto con un obiettivo di prezzo di $135.00 a $132.00. Il prezzo attuale a cui Illumina (ILMN) è scambiato è $95.61, che è out of del range previsto dall'analista.
Sfoglia valutazioni degli analisti e obiettivi di prezzo su tutte le azioni.